Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PERFECT - Portuguese Evolut Registry Studying the Outcomes of Medtronic Evolut™ FX+ TAVI System by Evaluating an Optimal Care Pathway for TAVI

NCT07343674 is registered in ClinicalTrials.gov with Portuguese Association of Interventional Cardiology as lead sponsor.

NCT NCT07343674
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07343674 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PERFECT - Portuguese Evolut Registry Studying the Outcomes of Medtronic Evolut™ FX+ TAVI System by Evaluating an Optimal Care Pathway for TAVI
Lead sponsor
Portuguese Association of Interventional Cardiology
Phase
Observational
Overall status
Recruiting
Start date
January 14, 2026
Completion date
April 30, 2028
Enrollment
500 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

severe symptomatic aortic stenosis (defined as new york heart association (nyha) class ≥ ii)